Dechra Pharmaceuticals PLC (LSE:DPH) - Share price - Overview

Stock Report

Dechra Pharmaceuticals PLC DPH

Last Price
GBX1,813.00

Day Change
-21.00|-1.15%

As of 18/05/2017
12:18:47 BST | GBX
Minimum 15 Minutes Delay.

Last Close1,834.00p
Day Range1,800.00 - 1,838.00
Mkt Cap1.71Bil
52-Wk Range811.00 - 1,851.00
Yield %0.96
ISINGB0009633180
Volume44,078
P/E70.78
P/S6.55
P/CF37.16

Share Price

Total Returns 17/05/2017

 Chg (%)  
More ...
Dechra Pharmaceuticals PLC9.82 
FTSE 100 TR GBP2.74
 
Financials
201420152016
More ...
Income Statement
Turnover193.57203.48247.56
Operating Profit25.0025.9819.49
Net Profit19.4219.4612.51
Reported EPS22.1421.9913.90
Balance Sheet
Current Assets86.33108.62162.46
Non Current Assets214.44184.90398.30
Total Assets300.77293.53560.75
Current Liabilities35.7244.1166.26
Total Liabilities95.9799.04284.14
Total Equity204.81194.49276.61
Cash Flow
Operating Cash Flow23.4046.9956.45
Net Change in Cash-4.1021.51-5.15
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201772.8960.93137.8730.100.2219.451.06
201886.3671.3517.1025.701.5021.381.17
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
03/05/2017Sale of Option SharesMr. Ian Page1,715.001,63027,955.00
02/05/2017Exercise of OptionMr. Ian Page552.001,6308,998.00
24/04/2017Transfer OutMr. Ian Page0.002,0000.00
24/04/2017Transfer OutMr. Ian Page0.002,0000.00

Company Profile

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company manufactures, develops and sells products for veterinarians.

Sector

Drug Manufacturers - Major

Market Position

221 of 1850 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Outlook

(27/02/2017) "...remains confident in our strategy, our future prospects and our expectations for full year performance"

Next Event 30/06/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)26.1615.1216.69
Div Yld (E)1.153.574.04
PEG (E)1.110.400.75
ROCE18.92186.66-69.55
Op Mrgn10.13-7.38-97.00
EPS Grwth23.6860.1128.99
Dividends
PreviousLatest
More ...
Record Date28/10/1610/03/17
Ex-Div27/10/1609/03/17
Paid18/11/1607/04/17
Amnt12.916.11

Broker Sentiment

Strong Buy0
Buy4
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Tony Rice
Chief ExecutiveMr. Ian Page
Chief Financial OfficerMr. Richard Cotton
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.